Jeff Schmitt
Jeff enjoys a rich life filled with science, music, art, and family. He did his undergraduate work at Wake Forest University followed by graduate fellowships at the University of Bath and Oxford University. Jeff holds an adjunct professorship at Wake Forest University Health Sciences in Physiology/Pharmacology and the Translational Sciences Institute. He is a founding team member of a leading biopharmaceutical company (Targacept, Inc.) where he led the creation one of a leading drug discovery platforms, Pentad™. Jeff has published 100 peer-reviewed publications, patents and abstracts, and is currently on the editorial advisory boards of 5 international scientific journals and is a Business Journal top patent holder. He has held Board positions on numerous non-profit organizations.
As a member of the leadership team of the American Association of Pharmaceutical Scientists, Jeff created the Computational Drug Design Focus Group in an effort to promote research in making drug design more efficient through computer simulation. Jeff also spearheaded the development of the first operational scientific computing grid in the Southeast (http://www.gridtoday.com/04/0105/102447.html) and has pioneered the use of quantum molecular dynamics in drug discovery (http://www.biotk.com/news_details.php?id=147). Currently, Jeff continues work with his colleagues at Wake Forest University Health Sciences on the design of cancer therapeutics.
